Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second most deadly cancer by 2040, owing to the high incidence of metastatic disease and limited responses to treatment(1,2). Less than half of all patients respond to the primary treatment for PDAC, chemotherapy(3,4), and genetic alterat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tintelnot, Joseph, Xu, Yang, Lesker, Till R., Schönlein, Martin, Konczalla, Leonie, Giannou, Anastasios D., Pelczar, Penelope, Kylies, Dominik, Puelles, Victor G., Bielecka, Agata A., Peschka, Manuela, Cortesi, Filippo, Riecken, Kristoffer, Jung, Maximilian, Amend, Lena, Bröring, Tobias S., Trajkovic-Arsic, Marija, Siveke, Jens T., Renné, Thomas, Zhang, Danmei, Boeck, Stefan, Strowig, Till, Uzunoglu, Faik G., Güngör, Cenap, Stein, Alexander, Izbicki, Jakob R., Bokemeyer, Carsten, Sinn, Marianne, Kimmelman, Alec C., Huber, Samuel, Gagliani, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977685/
https://www.ncbi.nlm.nih.gov/pubmed/36813961
http://dx.doi.org/10.1038/s41586-023-05728-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977685/
https://www.ncbi.nlm.nih.gov/pubmed/36813961
http://dx.doi.org/10.1038/s41586-023-05728-y

Ejemplares similares